Read + Share
Li R, Sant S, Brown E, Caramia F, et al. Tucatinib promotes immune activation and synergises with PD-1/PD-L1 inhibition in
HER2-positive breast cancer. J Natl Cancer Inst 2023 May 11:djad072. doi: 10.1093.
PMID: 37166471
|
 |
|
Li R, Sant S, Brown E, Caramia F, et al. Tucatinib promotes immune activation and synergises with PD-1/PD-L1 inhibition in
HER2-positive breast cancer. J Natl Cancer Inst 2023 May 11:djad072. doi: 10.1093.
PMID: 37166471
|
|
|
|